Professor Ahmet Fuat was a GP in Darlington, County Durham for 37 years, where he was CVD and Research Leads for Darlington Primary Care Network and Darlington GP Federation. He joined Oberoi Consulting as Medical Director in September 2023, and is soon to start as an Honorary Consultant Lipidologist/GPSI within the diabetes and endocrinology team at County Durham and Darlington Foundation Trust.

He has been a GPSI Cardiology for over 25 years, having undertaken a Postgraduate Diploma in Cardiology at Bradford University, graduating with distinction. He went on to be a tutor on the course for many years, teaching on HF, HVD, AF and IHD. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 2002, with local colleagues.

His PhD by research, in heart failure diagnosis and management, including work on natriuretic peptides, generated several publications that have informed guidelines and led to the award of an Honorary Professorial Chair at Durham University. He has contributed to various NICE and ESC CVD and HF guidelines, and RCGP CKD/AKI toolkit.

He has held and holds various roles in CVD and research, including the immediate past President of the Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming and current education and research lead, Lipid and Heart Failure primary care lead for North East and North Cumbria Academic Health Science Network. He sits on the NHSE CVD Prevention Clinical Leadership group and NHSE expert advisory group for Heart Failure and Heart Valve disease. He was a founder member of CaReMe UK representing the PCCS.

He has a passion for medical education and remains an active lecturer, tutor and researcher. He is on the editorial boards of the British Journal of Cardiology and Primary Care Cardiovascular Journals and a peer reviewer for most high impact Cardiovascular journals and research bodies. His work in community cardiology, has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh and the PCCS.

He has led many quality improvement initiatives over the years in HF, AF, Lipids, hypertension, diabetes and CKD. His work on HF was included in their BHF blueprint for HF. Much of this work was carried out using Oberoi digital audit platforms, as has been replicated by colleagues across the UK, benefiting patients and practices positively.

He oversees the clinical aspects of Oberoi Disease management digital platform developments in HF, AF, CKD, Diabetes and Lipids, ensuring they reflect current National/International guidelines, and enable primary care to achieve QOF, DES/IIF and CVDPrevent audit targets. He mentors and trains the team of HF specialist nurses and clinical pharmacists employed by Oberoi Consulting.